Stockreport

Epizyme's tazemetostat shows positive effect in mid-stage lymphoma study [Seeking Alpha]

Epizyme, Inc.  (EPZM) 
Last epizyme, inc. earnings: 2/24 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: epizyme.com
PDF Epizyme's tazemetostat shows positive effect in mid-stage lymphoma studyPreliminary results from a Phase 2 clinical trial evaluating Epizyme's (NASDAQ:EPZM) lead drug ta [Read more]